1932

Abstract

There is significant interest in developing transcatheter therapy for valvular heart disease (VHD). Numerous devices have been developed for the percutaneous treatment of pulmonary and aortic stenosis as well as mitral regurgitation. Several of these devices have progressed to randomized clinical trials. These ongoing trials for aortic stenosis and mitral regurgitation will provide important insights into the durability of these therapies as well as the results following standard surgical repair. The field of transcatheter valve therapy is rapidly evolving, and this review aims to summarize the current status of the field.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.60.042907.172833
2009-02-18
2024-06-24
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.60.042907.172833
Loading
/content/journals/10.1146/annurev.med.60.042907.172833
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error